PMID- 28944872 OWN - NLM STAT- MEDLINE DCOM- 20180606 LR - 20181113 IS - 1791-3004 (Electronic) IS - 1791-2997 (Print) IS - 1791-2997 (Linking) VI - 16 IP - 5 DP - 2017 Nov TI - Isoflurane exposure regulates the cell viability and BDNF expression of astrocytes via upregulation of TREK‑1. PG - 7305-7314 LID - 10.3892/mmr.2017.7547 [doi] AB - Neonatal isoflurane exposure in rodents disrupts hippocampal cognitive functions, including learning and memory, and astrocytes may have an important role in this process. However, the molecular mechanisms underlying this disruption are not fully understood. The present study investigated the role of TWIK‑related K+ channel (TREK‑1) in isoflurane‑induced cognitive impairment. Lentiviruses were used to overexpress or knockdown TREK‑1 in astrocytes exposed to increasing concentrations of isoflurane or O2 for 2 h. Subsequently, the mRNA and protein expression of brain‑derived neurotrophic factor (BDNF), caspase‑3, Bcl‑2‑associated X (Bax) and TREK‑1 was measured by reverse transcription‑ quantitative polymerase chain reaction and western blot analysis, respectively. In addition, cell viability was assessed by a 2‑(4‑Iodophenyl)‑3‑(4‑nitrophenyl)‑5‑(2,4‑disulfophenyl)‑ 2H‑tetrazolium monosodium salt assay. The results demonstrated that, prior to manipulating TREK‑1, isoflurane significantly decreased the cell viability and BDNF expression, and increased Bax, caspase‑3 and TREK‑1 expression was observed. However, TREK‑1 overexpression in astrocytes significantly downregulated BDNF expression, and upregulated Bax and caspase‑3 expression. Furthermore, lentiviral‑mediated short hairpin RNA knockdown of TREK‑1 effectively inhibited the isoflurane‑induced changes in BDNF, Bax and caspase‑3 expression. Taken together, the results of the present study indicate that isoflurane‑induced cell damage in astrocytes may be associated with TREK‑1‑mediated inhibition of BDNF and provide a reference for the safe use of isoflurane anesthesia in infants and children. FAU - Zhou, Cui-Hong AU - Zhou CH AD - Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China. FAU - Zhang, Ya-Hong AU - Zhang YH AD - Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China. FAU - Xue, Fen AU - Xue F AD - Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China. FAU - Xue, Shan-Shan AU - Xue SS AD - Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China. FAU - Chen, Yun-Chun AU - Chen YC AD - Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China. FAU - Gu, Ting AU - Gu T AD - Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China. FAU - Peng, Zheng-Wu AU - Peng ZW AD - Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China. FAU - Wang, Hua-Ning AU - Wang HN AD - Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China. LA - eng PT - Journal Article DEP - 20170920 PL - Greece TA - Mol Med Rep JT - Molecular medicine reports JID - 101475259 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Potassium Channels, Tandem Pore Domain) RN - 0 (RNA, Messenger) RN - 0 (RNA, Small Interfering) RN - 0 (bcl-2-Associated X Protein) RN - 0 (potassium channel protein TREK-1) RN - CYS9AKD70P (Isoflurane) RN - EC 3.4.22.- (Caspase 3) SB - IM MH - Animals MH - Astrocytes/cytology/drug effects/metabolism MH - Brain-Derived Neurotrophic Factor/genetics/*metabolism MH - Caspase 3/genetics/metabolism MH - Cell Survival/drug effects MH - Cells, Cultured MH - Female MH - Isoflurane/*pharmacology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Potassium Channels, Tandem Pore Domain/antagonists & inhibitors/genetics/*metabolism MH - RNA Interference MH - RNA, Messenger/metabolism MH - RNA, Small Interfering/metabolism MH - Up-Regulation/*drug effects MH - bcl-2-Associated X Protein/genetics/metabolism PMC - PMC5865860 EDAT- 2017/09/26 06:00 MHDA- 2018/06/07 06:00 PMCR- 2017/09/20 CRDT- 2017/09/26 06:00 PHST- 2017/01/11 00:00 [received] PHST- 2017/07/26 00:00 [accepted] PHST- 2017/09/26 06:00 [pubmed] PHST- 2018/06/07 06:00 [medline] PHST- 2017/09/26 06:00 [entrez] PHST- 2017/09/20 00:00 [pmc-release] AID - mmr-16-05-7305 [pii] AID - 10.3892/mmr.2017.7547 [doi] PST - ppublish SO - Mol Med Rep. 2017 Nov;16(5):7305-7314. doi: 10.3892/mmr.2017.7547. Epub 2017 Sep 20.